Screener
Madrigal Pharmaceuticals, Inc. MDGL Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The source filing: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 9:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050845
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Marketable securities | 546,027 | 784,866 |
| Trade receivables, net | 192,311 | 134,476 |
| Inventory | 99,391 | 74,841 |
| Prepaid expenses and other current assets | 68,570 | 47,804 |
| Total current assets | 1,199,180 | 1,245,770 |
| Property and equipment, net | 11,592 | 1,499 |
| Intangible assets, net | 7,187 | 7,381 |
| Operating lease right-of-use assets | 5,578 | 4,939 |
Item 1. Financial Statements (Unaudited):
FAQ
- What is Madrigal Pharmaceuticals, Inc.'s prepaid & other current?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported prepaid & other current of $68.57M in Q2 2026.
- How has Madrigal Pharmaceuticals, Inc.'s prepaid & other current changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s prepaid & other current increased by 17.0% year-over-year, from $58.6M to $68.57M.
- What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s prepaid & other current?
- Over 5 years (2020 to 2025), Madrigal Pharmaceuticals, Inc.'s prepaid & other current has grown at a 116.1% compound annual growth rate (CAGR), from $1.01M to $47.8M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.
Ask your AI about Madrigal Pharmaceuticals, Inc.'s prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude